KRT19 and breast cancer: In an early series of 133 patients with invasive breast cancer, Grünewald et al [26], found that mammaglobin (SCGB2) transcripts were a specific marker for hematogenous spread of breast cancer cells, but that KRT19 mRNA expression was not specific because it was expressed in 39% of healthy volunteers.